Endogenous / BiologyEndogenousHuman-supportedUpdated 2026-04-24

Peptide reference file

VIP

Trending #21 in Endogenous8.4k searches/moProven

Vasoactive intestinal peptide is an endogenous neuropeptide with vasodilatory, pulmonary, gut, and immune-signaling roles.

Current readout: human-supported evidence, endogenous status, endogenous approval state, human evidence appears in the current trail, registered trials are linked, and 3 linked sources in the seed trail.

PubChem CID 53314964 | 46131 PubMed results | 121 trial records | 54 DailyMed labels | 0 Drugs@FDA applications

VIP is mostly discussed because it matters because it sits behind aviptadil-like clinical discussions and a wide range of physiological effects.

The public claim is straightforward: It matters because it sits behind aviptadil-like clinical discussions and a wide range of physiological effects. Strong human physiology relevance with translational importance.

In plain language, vasoactive intestinal peptide is an endogenous neuropeptide with vasodilatory, pulmonary, gut, and immune-signaling roles.

Human-supportedEndogenous
NeuropeptideVasodilationPulmonary and gut signaling

Aliases: Vasoactive intestinal peptide, Aviptadil endogenous reference

SpecimenVIP specimen
CCCCHHHHHHHNOS
Formula
C147H237N43O43S
Mass
3326.8
Evidence
Human-supported
Elements
5

Most commonly discussed in relation to Neuropeptide, Vasodilation, Pulmonary and gut signaling.

What VIP is

Vasoactive intestinal peptide is an endogenous neuropeptide with vasodilatory, pulmonary, gut, and immune-signaling roles.

VIP is grouped under Endogenous / Biology / Approved / Clinical on PeptideFactCheck because it matters because it sits behind aviptadil-like clinical discussions and a wide range of physiological effects.

The useful starting point is to separate the molecule itself from the internet story around it. It matters because it sits behind aviptadil-like clinical discussions and a wide range of physiological effects.

Why people keep looking it up

It matters because it sits behind aviptadil-like clinical discussions and a wide range of physiological effects.

Vasoactive intestinal peptide is an endogenous neuropeptide with vasodilatory, pulmonary, gut, and immune-signaling roles.

VIP tends to stay in the conversation because it touches a familiar public theme: neuropeptide, vasodilation, and pulmonary and gut signaling. That makes it easy for the claim to travel faster than the evidence.

What the evidence can support right now

Strong human physiology relevance with translational importance.

Human biology is well described, but this entry is about the endogenous peptide rather than any investigational analog program.

Mechanistic support is extensive across pulmonary, gut, and neuroimmune physiology.

Why this page carries the current tier: Strong human physiology relevance with translational importance.

The current seed trail for VIP is pulling from 2 databases sources and 1 literature source.

Safety, limits, and regulatory context

Broad physiology makes it easy to oversimplify what VIP-based therapeutics can actually do.

VIP is tracked here as endogenous biology rather than an FDA-approved drug product.

Editorial boundary: PeptideFactCheck does not publish dosing, cycling, sourcing, injection, or administration instructions for VIP. The job here is to explain the public claim, the mechanism story, the evidence strength, and the current limits.

Molecular and identifier data

The current PubChem match for VIP is CID 53314964. That gives the page a source-backed chemistry record rather than a placeholder identifier block.

PubChem CID
53314964
Formula
C147H237N43O43S
Molecular weight
3326.8
InChIKey
VBUWHHLIZKOSMS-RIWXPGAOSA-N

Matched synonyms include VASOACTIVE INTESTINAL PEPTIDE, 37221-79-7, 6J2WVD66KR, His-Ser-Asp-Ala-Val-Phe-Thr-Asp-Asn-Tyr-Thr-Arg-Leu-Arg-Lys-Gln-Met-Ala-Val-Lys-Lys-Tyr-Leu-Asn-Ser-Ile-Leu-Asn, UNII-6J2WVD66KR, CCRIS 7231, VIP [MI], Vasoactive intestinal peptide, synthetic porcine.

Open PubChem record

Clinical trial snapshot

The current ClinicalTrials.gov intervention query for VIP returns 121 study records. This does not prove efficacy by itself, but it does show whether the peptide is showing up in a formal trial registry rather than only in forums or vendor copy.

Literature snapshot

The current PubMed query for VIP returns 46131 results. The articles below are a quick literature surface so the page shows actual papers instead of only generic evidence labels.

Label and regulatory records

For approved or clinically developed peptides, the page now pulls in official labeling and FDA-facing records where they exist. That makes the regulatory section materially more useful than a generic approved or not-approved tag.

Brand names
Joette Calabrese Survivalist Kit
Generic names
ABROT ACON AGN AIL AMBR AMBRO AM-C ANT-C APIS ARN ARS AUR-A AUR BAPT BAR-C BELL BB BOTH BOV BROM CADM-S CALAD CALC CAMPH CARB-AC CARD-M CEAN CHEL CHININ-A CINA CHIN CIC COB COLCH CON CROT-H CROT-T CUPR DULC ELAPS EUP-PER FL-AC GALPH GRAPH GUNP HAM HEKLA HELL HEP HYDR-AC HYOS HYPER KALI-BR KALI-C KALI-I LATH LAUR LED LOB MERC-CY MERC MEZ MOSCH MUR-AC NAJA NAT-C NIT-AC NUX-M PYROG PH-AC PIC-AC PLB RHUS-T RUTA SAMB SANG SARR SEP STRAM SUL-AC TAB TERENT TER TEUCR VERAT VERAT-V VIP
Routes
ORAL
Application numbers
Not linked

Indications and usage. ACTIVE INGREDIENTS (HPUS*) PURPOSE**: ABROTANUM 6C (intestines), ACONITUM NAPELLUS 1M (shock), AETHUSA CYNAPIUM 200C (dairy intolerance), AGNUS CASTUS 200C (impotence/absentmindedness), AILANTHUS GLANDULOSUS 30C (fever/glands), AMBRA GRISEA 30C (confusion/memory), AMBROSIA ARTEMISIAEFOLIA 30C (itchy eyelids), AMMONIUM CARBONICUM 30C (breathing), ANTIMONIUM CRUDUM 6C, 200C (rash), APIS MELLIFICA 1M (swellings), ARNIC...

PLUVICTO (LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN) INJECTION, SOLUTION [NOVARTIS PHARMACEUTICALS CORPORATION]Apr 17, 202614908037-2892-4d98-a053-253ce35afb1aOpen labelVARICOSE VEINS (ELAPS CORALLINUS, CROTALUS HORRIDUS, BRYONIA, CALC. FLUOR., CARDUUS MAR., CHOLESTERINUM, CINCHONA, DIGITALIS, HAMAMELIS, HYDROFLUORICUM ACIDUM, LACHESIS, LYCOPODIUM, NAJA, PULSATILLA, VIPERA BERUS, ZINC. MET., AESCULUS HIPP., ECHINACEA) LIQUID [NEWTON LABORATORIES, INC.]Feb 02, 202691e8e37c-c654-6df9-e053-2995a90aafe1Open labelHEADACHE (ELAPS CORALLINUS, ARSENICUM ALB., BELLADONNA, BRYONIA, CARDUUS BENEDICTUS, CIMICIFUGA, COFFEA CRUDA, CONVALLARIA, CROTALUS HORRIDUS, DIGITALIS, GELSEMIUM, GLONOINUM, IGNATIA, LACHESIS, MERC. VIV., NAJA, NUX VOM., PHOSPHORUS, RHUS TOXICODENDRON, SANGUINARIA, SECALE, VIPERA BERUS, APIS MEL., HYPERICUM, THUJA OCC..) LIQUID [NEWTON LABORATORIES, INC.]Dec 04, 202544ffafd7-8b43-5a24-e063-6294a90a80a3Open labelHEADACHE (ELAPS CORALLINUS, ARSENICUM ALB., BELLADONNA, BRYONIA, CARDUUS BENEDICTUS, CIMICIFUGA, COFFEA CRUDA, CONVALLARIA, CROTALUS HORRIDUS, DIGITALIS, GELSEMIUM, GLONOINUM, IGNATIA, LACHESIS, MERC. VIV., NAJA, NUX VOM., PHOSPHORUS, RHUS TOXICODENDRON, SANGUINARIA, SECALE, VIPERA BERUS, APIS MEL., HYPERICUM, THUJA OCC..) PELLET [NEWTON LABORATORIES, INC.]Dec 04, 202544ffb50a-7bfe-428b-e063-6394a90a9dcfOpen labelHEADACHE-MIGRAINE (ELAPS CORALLINUS, ARSENICUM ALB., BELLADONNA, BRYONIA, CARDUUS BENEDICTUS, CIMICIFUGA, COFFEA CRUDA, CONVALLARIA, CROTALUS HORRIDUS, DIGITALIS, GELSEMIUM, GLONOINUM, IGNATIA, LACHESIS, MERC. VIV., NAJA, NUX VOM., PHOSPHORUS, RHUS TOXICODENDRON, SANGUINARIA, SECALE, VIPERA BERUS, APIS MEL., HYPERICUM, THUJA OCC..) LIQUID [NEWTON LABORATORIES, INC.]Dec 04, 202545002cee-75e1-1d1a-e063-6294a90a6e0dOpen label

Source trail

Each linked source is shown directly so the page can be audited. The page now combines its editorial seed trail with automated official-source enrichment generated on 2026-04-24 from PubChem, ClinicalTrials.gov, PubMed, DailyMed, openFDA label, and Drugs@FDA.

Safety noteThis content is educational only and does not replace medical advice. Peptide use may carry risks and should be discussed with a qualified medical professional.